Skip to content
Clinical Trials – home

University Of Pecs

Verified siteinfo

Hungary Rakoczi Ut 2, 7623 Pecs, Hungary

  • 83 trials recruiting
  • Hidradenitis · Non-small cell lung cancer · Dermatitis atopic
  • Adults and children

About Specializations

University Of Pecs in Pecs, Hungary specialises in clinical trials of conditions such as Hidradenitis, Non-small cell lung cancer, Dermatitis atopic, Endocrine ophthalmopathy, and other specialisations. This site conducts important research.

Main research areas of the site

Neoplasms and Hematologic Oncology at University Of Pecs

Research at the Department of pediatrics focuses on acute lymphoblastic leukemia, with an emphasis on improving outcomes for infants and other pediatric patients affected by this serious cancer. The trials in this area are aimed at testing better treatment strategies and strengthening long-term disease control.

  • Improving event-free survival for infants with newly diagnosed acute lymphoblastic leukemia
  • Evaluating treatment effectiveness in high-risk pediatric blood cancer care
  • Advancing care for infant leukemia through clinically focused research

This work reflects a strong commitment to pediatric cancer research at University Of Pecs, with the goal of helping clinicians achieve better outcomes for young patients.

Diagnostic Imaging and Contrast-Enhanced MRI

Another major research area at the site involves analytical, diagnostic and therapeutic techniques and equipment, especially studies related to contrast enhancement in magnetic resonance imaging in children. These trials are designed to improve the understanding of imaging agents and support safer, more effective diagnostic evaluation in pediatric care.

  • Studying contrast-enhanced MRI in children undergoing diagnostic imaging
  • Assessing how imaging agents behave in the body to support safer use
  • Improving diagnostic tools for pediatric patients at University Of Pecs

The research helps expand knowledge of pediatric imaging and supports better diagnostic decision-making for children across a range of clinical settings.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Rakoczi Ut 27623 PecsHungary
Recruiting now
83 trials
Conditions studied
152
Partner status
Verified site

More sites in PecsHungary

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

212 clinical trials

A Phase 3 Randomized Study of mRNA‑4157 plus Pembrolizumab as Adjuvant Therapy in Patients with Completely Resected Stage I Non‑Small Cell Lung Cancer

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:MRNA-4157
  • Sponsor:Merck Sharp & Dohme LLC

Hidradenitis

Recruiting

Long-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Remibrutinib
  • Sponsor:Novartis Pharma AG

Phase III Randomized Study of Rilvegostomig vs. Pembrolizumab with Platinum-based Chemotherapy in PD-L1 Expressing Metastatic Squamous NSCLC

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:AstraZeneca AB

Study of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Zilebesiran
  • Sponsor:Alnylam Pharmaceuticals Inc.

Vitiligo

Recruiting

Study of ruxolitinib cream for children aged 6 to 12 years with non-segmental vitiligo

Investigational
Countries:HungaryHungary
  • Participants:0–17 years
  • Substances:Ruxolitinib
  • Sponsor:Incyte Corp.

Study of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:BI 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.

Study of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Sponsor:AstraZeneca AB

Study on Tozorakimab for Patients Hospitalized with Severe Viral Lung Infections Needing Oxygen

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Tozorakimab
  • Sponsor:AstraZeneca AB

Study comparing rilvegostomig plus chemotherapy versus pembrolizumab plus chemotherapy for first-line treatment in patients with metastatic non-squamous lung cancer with PD-L1 expression

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:AstraZeneca AB

Cardiac failure

Recruiting

Study on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:BI 690517
  • Sponsor:Boehringer Ingelheim International GmbH

Study on the Safety of BHV-7000 for Adults with Hard-to-Treat Focal Onset Epilepsy

InvestigationalNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:BHV-7000
  • Sponsor:Biohaven Therapeutics Ltd.

Eyelid ptosis

Recruiting

Study on the Effectiveness and Safety of Oxymetazoline Hydrochloride Eye Drops for Adults with Acquired Blepharoptosis

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Oxymetazoline Hydrochloride
  • Sponsor:Santen
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.